Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women | Zendy

Alex Peahl | Zendy; Vanessa K. Dalton | Zendy; John R. Montgomery | Zendy; Yen-Ling Lai | Zendy; Hsou Mei Hu | Zendy; Jennifer F. Waljee | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women

Author(s) -

Alex Peahl,

Vanessa K. Dalton,

John R. Montgomery,

Yen-Ling Lai,

Hsou Mei Hu,

Jennifer F. Waljee

Publication year - 2019

Publication title -

jama network open

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.278

H-Index - 39

ISSN - 2574-3805

DOI - 10.1001/jamanetworkopen.2019.7863

Subject(s) - medicine , medical prescription , retrospective cohort study , pharmacy , obstetrics , opioid , cohort study , pregnancy , vaginal delivery , anesthesia , family medicine , receptor , biology , pharmacology , genetics

Key Points Question What are the rates of new persistent opioid use among women who receive an opioid prescription after undergoing vaginal or cesarean delivery? Findings In this US national cohort study of 308 226 deliveries, women who received a peripartum opioid prescription had rates of new persistent opioid use of 1.7% for vaginal delivery and 2.2% for cesarean delivery. Prescription size and filling a prescription before delivery were associated with new persistent opioid use. Meaning These results suggest that maternity care clinicians can potentially decrease new persistent opioid use among women after either vaginal or cesarean delivery through judicious opioid prescribing.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research